Six Major Pharma Companies To Invest Rs 5,260 Crore In Telangana

Hyderabad:  Major pharmaceutical companies have promised investments to the tune of Rs 5,260 crore for setting up new units and expanding operations in the existing ones in Telangana.

Representatives of the pharma industries called on Chief Minister A. Revanth Reddy at the Secretariat on Friday afternoon and signed memoranda of understanding with the State Government in his presence. They assured to set up green industry without giving scope for pollution. The MoUs would help create 12,490 new jobs in the pharma sector and the State Government would provide land for the units in the proposed pharma city.

According to the MoUs, MSN Laboratories would set up a manufacturing facility as well as research and development centres and Laurus Labs and Aurobindo Pharma would set up formulation units while the Gland Pharma would set up an R&D centre as well as injectables and drug substance manufacturing unit. Dr. Reddy’s Labs on its part would set up injectables and biosimilar facility while Hetero Labs assured to set up plant for finished dosages and injectables.

The Chief Minister directed the officials concerned to take steps to allot lands for the pharma units to set up their units besides ensuring the necessary facilities for their operations.

Dr. Reddy’s Labs director Satish Reddy, Laurus Labs executive director V.V. Ravi Kumar, Gland Pharma chief executive officer Srinivas and Hetero Group managing director Vamsi Krishna were among others who called on the Chief Minister.

Related Posts

  • Pharma
  • June 17, 2025
  • 101 views
Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Bengaluru-based biopharmaceutical firm Biocon on Monday launched a qualified institutions placement (QIP) to raise Rs 4,500 crore. As part of the offering, the firm will issue up to 139 million…

  • Pharma
  • June 17, 2025
  • 102 views
Zydus Healthcare appoints Swati Dalal MD

Zydus Lifesciences Ltd on Monday announced the appointment of Swati Dalal as an additional director and Managing Director of its wholly-owned arm Zydus Healthcare Ltd. The board of Zydus Healthcare…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Zydus Healthcare appoints Swati Dalal MD

Zydus Healthcare appoints Swati Dalal MD

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco API plant gets one observation from FDA

Natco API plant gets one observation from FDA